Pulik Richard reported option exercise involving 127,365 derivative units of Roivant Sciences Ltd. at $0.00 for $0 on Nov 11, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CFO
CFO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
127,365Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
487,635Direct
Trade date
Nov 11, 2026Option exercise
Filed
Nov 12, 2026, 7:01 PM ET2-day reporting delay
Accession
0001635088-26-000139Code M · Transaction 399892
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell125,000$41.20−$5,150,000Trade 399886
Nov 11, 2026Sell45,195$41.47−$1,874,236.65Trade 399888
Nov 11, 2026Sell82,170$42.03−$3,453,605.10Trade 399889
Nov 11, 2026Sell47,635$41.89−$1,995,430.15Trade 399890
Nov 10, 2026Option exercise125,000$3.85$481,250Trade 399885
Nov 11, 2026Option exercise127,365$3.85$490,355.25Trade 399887
Nov 10, 2026Option exercise125,000$0.00$0Trade 399891
8 transaction rows in this filing. Joint filers share the same rows.

ROIV price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ROIV · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −14%1w ago −4.4%1d ago +3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.16 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.88 to $41.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.94 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F5: Reflects an award of stock options to purchase Common Shares that is fully vested.